ZNF143-mediated H3K9 trimethylation upregulates CDC6 by activating MDIG in hepatocellular carcinoma

L Zhang, Q Huo, C Ge, F Zhao, Q Zhou, X Chen, H Tian… - Cancer Research, 2020 - AACR
L Zhang, Q Huo, C Ge, F Zhao, Q Zhou, X Chen, H Tian, T Chen, H Xie, Y Cui, M Yao, H Li…
Cancer Research, 2020AACR
Abstract Zinc finger protein 143 (ZNF143) belongs to the zinc finger protein family and
possesses transcription factor activity by binding sequence-specific DNA. The exact
biological role of ZNF143 in hepatocellular carcinoma (HCC) has not been investigated.
Here we report that ZNF143 is overexpressed in HCC tissues and its overexpression
correlates with poor prognosis. Gain-and loss-of-function experiments showed that ZNF143
promoted HCC cell proliferation, colony formation, and tumor growth in vitro and in vivo …
Abstract
Zinc finger protein 143 (ZNF143) belongs to the zinc finger protein family and possesses transcription factor activity by binding sequence-specific DNA. The exact biological role of ZNF143 in hepatocellular carcinoma (HCC) has not been investigated. Here we report that ZNF143 is overexpressed in HCC tissues and its overexpression correlates with poor prognosis. Gain- and loss-of-function experiments showed that ZNF143 promoted HCC cell proliferation, colony formation, and tumor growth in vitro and in vivo. ZNF143 accelerated HCC cell-cycle progression by activating cell division cycle 6 (CDC6). Mechanistically, ZNF143 promoted expression of CDC6 by directly activating transcription of histone demethylase mineral dust–induced gene (MDIG), which in turn reduced H3K9me3 enrichment in the CDC6 promoter region. Consistently, ZNF143 expression correlated significantly with MDIG and CDC6 expression in HCC. Collectively, we propose a model for a ZNF143–MDIG–CDC6 oncoprotein axis that provides novel insight into ZNF143, which may serve as a therapeutic target in HCC.
Significance
These findings describe the mechanism by which ZNF143 promotes HCC proliferation and provide important clues for exploring new targets and strategies for clinical treatment of human liver cancer.
AACR